Technical Analysis for AURA - Aura Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| 20 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | -0.40% | |
| Crossed Above 20 DMA | Bullish | -0.40% | |
| Pocket Pivot | Bullish Swing Setup | -0.40% | |
| Gapped Up | Strength | -0.40% |
| Alert | Time |
|---|---|
| Gap Up Closed | about 17 hours ago |
| Gap Up Partially Closed | about 17 hours ago |
| 50 DMA Resistance | about 17 hours ago |
| 10 DMA Resistance | about 17 hours ago |
| Down 3% | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.5 |
| 52 Week Low | 5.9906 |
| Average Volume | 190,717 |
| 200-Day Moving Average | 8.61 |
| 50-Day Moving Average | 7.61 |
| 20-Day Moving Average | 7.39 |
| 10-Day Moving Average | 7.53 |
| Average True Range | 0.40 |
| RSI (14) | 50.25 |
| ADX | 18.44 |
| +DI | 28.41 |
| -DI | 15.63 |
| Chandelier Exit (Long, 3 ATRs) | 6.90 |
| Chandelier Exit (Short, 3 ATRs) | 8.08 |
| Upper Bollinger Bands | 7.87 |
| Lower Bollinger Band | 6.91 |
| Percent B (%b) | 0.61 |
| BandWidth | 13.05 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0165 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.58 | ||||
| Resistance 3 (R3) | 8.62 | 8.29 | 8.40 | ||
| Resistance 2 (R2) | 8.29 | 8.02 | 8.28 | 8.34 | |
| Resistance 1 (R1) | 7.90 | 7.85 | 7.74 | 7.86 | 8.28 |
| Pivot Point | 7.57 | 7.57 | 7.49 | 7.56 | 7.57 |
| Support 1 (S1) | 7.18 | 7.30 | 7.02 | 7.14 | 6.72 |
| Support 2 (S2) | 6.85 | 7.13 | 6.84 | 6.66 | |
| Support 3 (S3) | 6.46 | 6.85 | 6.60 | ||
| Support 4 (S4) | 6.42 |
